Electronic Repeat Dispensing is one of the quieter success stories of English primary care — and also one of its more visible under-used tools. It lets a GP prescribe up to 12 months of a stable medicine in a single batch, which the patient then collects at intervals from a nominated pharmacy without needing to request each refill from the practice.

The patient benefit is obvious. The GP benefit is equally obvious: around a quarter of all GP prescription workload is repeat authorisation. The NHS benefit is the reduced administrative overhead of prescription request, re-authorisation and fulfilment. And yet, as of 2026, eRD accounts for only around a third of all repeat prescription items in England despite being technically possible for most stable repeats.

This guide explains what eRD is, who it suits, why uptake lags, and how patients can ask for it.

What eRD is

A traditional repeat prescription works like this: the GP issues an authorisation for, say, six months. The patient orders each prescription separately, the practice prints or issues each token, and the pharmacy dispenses each one. Every single refill triggers an administrative action.

An eRD prescription compresses this. The GP issues a batch prescription — typically for 6 or 12 months, divided into issues of one or two months. All issues are stored in the NHS Spine at the point of authorisation. The patient's nominated pharmacy pulls down the next issue when it is due, prepares the supply, and contacts the patient for collection. No re-request is needed in between.

The patient is still free to cancel, change pharmacy or change medicine at any time. The prescription is not locked in — it is just pre-prepared.

Who it suits

The standard criteria for eRD suitability follow the clinical pattern of a stable long-term medicine:

• The medicine is a repeat, not an acute
• The dose is stable and has been for some months
• The patient has a nominated pharmacy
• The medicine is not a Schedule 2 or 3 controlled drug (these have separate rules)
• The patient's condition is stable and the review date is not about to fall

Typical eRD-suitable medicines include long-term statins, antihypertensives (amlodipine, ramipril, losartan), long-term thyroxine, long-term metformin, long-term inhalers for stable asthma, long-term contraceptive pills after the initial stabilisation period, and many repeat ointments and creams.

Medicines that are not generally suitable include newly started medicines still being titrated, medicines with doses that change frequently, and Schedule 2/3 controlled drugs.

Why uptake lags

Three reasons dominate.

First, habit. Many patients have been requesting monthly repeats for years and do not know eRD exists. The transition needs a practice or pharmacy to actively offer it — which takes a couple of minutes that neither side always has.

Second, pharmacy cashflow preferences. A community pharmacy is paid per item dispensed, and the cashflow implications of eRD are a wash — the items are the same — but the predictability of eRD is actually a benefit to the pharmacy. Some older pharmacy dispensing systems handle eRD better than others, and the transition is easier at branches with modern clinical systems.

Third, practice workflow. A small number of GP practices are still reluctant to authorise 12 months at a time, preferring the 6-month cycle for review purposes. This is legitimate clinical judgement but it also means eRD gets used in 6-issue batches rather than 13-issue ones, reducing the administrative gain.

A 2023 NHS England report noted that eRD saves an estimated 1–2 minutes of practice admin time per repeat item, and at scale this adds up to thousands of GP hours a year per integrated care board. The economic case is clear; the implementation is uneven.

How to ask for it

Three practical steps for a patient who wants to use eRD.

1. Nominate a pharmacy. eRD requires a nominated pharmacy — the single community pharmacy that will receive the electronic prescription. Nomination can be done at the pharmacy itself, through the NHS App, or at a GP practice. See PharmSee's guide to the NHS App and nominated pharmacy for the step-by-step.

2. Ask the GP or pharmacist to review medicines for eRD suitability. At the next repeat review, ask explicitly whether the current repeat list can be converted to eRD. Many practices will do this with a single appointment or a medication review note. A community pharmacist can also prompt this with the GP on the patient's behalf.

3. Set a calendar reminder for the review date. The main patient-facing responsibility with eRD is remembering when the whole batch expires. eRD does not remove the need for periodic medicine review; it just removes the need for per-item request.

What the pharmacy will do

Once eRD is set up, the nominated pharmacy pulls each issue from the Spine in advance of the expected collection date, dispenses the medicine, and contacts the patient by text, email or phone when it is ready. The patient collects as normal.

If the patient misses a collection, the next issue date remains fixed in the prescription sequence. If the patient changes pharmacy, the existing eRD prescription cancels and a new arrangement needs to be set up.

The common misconceptions

"eRD means I lose control of my medicine." No — the patient can cancel at any time by contacting the practice, pharmacy, or via the NHS App.

"eRD locks me into one pharmacy forever." No — nomination can be changed at any time, and the eRD prescription will move with the new nomination (subject to what has already been issued).

"eRD means I never see a GP about the medicine again." No — the review date still applies. eRD removes the per-item request burden, not the clinical review.

"eRD doesn't exist for my medicine." Probably not true. If the medicine is a stable repeat not on a controlled drug schedule, eRD is almost certainly technically available. The question is whether the GP has authorised it.

Where eRD fits in the broader prescription picture

eRD is one of several Electronic Prescription Service features that have developed over the past decade. EPS itself is near-universal — more than 95 per cent of English primary care prescriptions are now electronic. See PharmSee's EPS guide for the broader context.

Nominated pharmacy is the single most important practical step for anyone managing a long-term condition. After that, eRD is the next efficiency gain. Combined, they cut patient prescription admin substantially.

For branch locations and the pharmacies that actively manage eRD well, PharmSee's pharmacy finder covers every English community pharmacy.

Caveats

eRD eligibility and issue length are decisions made by the prescribing GP or clinical pharmacist and may not match every patient's medicine profile. Uptake figures quoted reflect NHS Digital public data trends and will continue to change. Controlled drug rules and specific policies vary by clinical commissioning footprint.